ReviewClinical & experimental optometry2019

Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension.

Murray Fingeret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.